Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR

Last updated on 2019-05-23 History
Report ID 13528
Drug Identification Number 02443449
Brand name MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Common or Proper name NAPROXEN/ESOMEPRAZOLE MR
Company Name MYLAN PHARMACEUTICALS ULC
Active Ingredient(s) ESOMEPRAZOLE NAPROXEN
Strength(s) 20MG 500MG
Dosage form(s) TABLET (IMMEDIATE AND DELAYED-RELEASE)
Route of administration ORAL
Packaging size 60BT
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-05-15
Actual start date
Estimated end date 2019-05-22
Actual end date 2019-05-22
Shortage status Resolved
Updated date 2019-05-23
Company comments
Health Canada comments
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v85 2019-05-23 English Compare
v84 2019-05-22 French Compare
v83 2019-05-22 English Compare
v82 2019-05-16 English Compare
v81 2019-05-14 French Compare
v80 2019-05-14 English Compare
v79 2019-05-09 English Compare
v78 2019-05-08 French Compare
v77 2019-05-08 English Compare
v76 2019-05-02 English Compare
v75 2019-04-30 French Compare
v74 2019-04-30 English Compare
v73 2019-04-27 English Compare
v72 2019-04-23 French Compare
v71 2019-04-23 English Compare
v70 2019-04-16 French Compare
v69 2019-04-16 English Compare
v68 2019-04-10 French Compare
v67 2019-04-10 English Compare
v66 2019-04-03 French Compare

Showing 1 to 20 of 85